JAMDA
September 17, 2020
Showing 41 - 50 of 2872 results
JAMDA
March 21, 2023
Trends in Risk-Adjusted Initiation and Reduction of Opioid Use among Veterans With Dementia in US Department of Veterans Affairs Community Living Centers
Proper initiation and reduction of opioids is important in providing effective and safe pain relief to Veterans with dementia, including in Community Living Centers (CLCs). We examined the trends in aggregated monthly risk-adjusted opioid administration days and dosage over 3 opioid safety regulatory perio...
JAMDA
October 28, 2021
Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer’s Disease
Antipsychotic use for neuropsychiatric symptoms in Alzheimer’s disease (AD) is common despite the increased risk of cardiovascular events and mortality. There is limited and inconsistent evidence on the possible risk of stroke. We assessed whether antipsychotic initiation increases the risk of stroke in pe...
JAMDA
October 25, 2019
Optimizing Practices, Use, Care and Services–Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices
Antipsychotic medications are often used for the first-line management of behavioral and psychological symptoms of dementia (BPSD) contrary to guideline recommendations. The Optimizing Practices, Use, Care and Services–Antipsychotics (OPUS-AP) strategy aims to improve the well-being of long-term care (LTC)...
JAMDA
August 1, 2022
Association Between Long-Term Care Facility Staffing Levels and Antipsychotic Use in US Long-Term Care Facilities
Inappropriate use of antipsychotics is an indicator of quality of care in long-term care (LTC) facilities. There is evidence to suggest that staffing levels in LTC may be associated with the rates of inappropriate antipsychotic use. This study sought to examine the association between staffing and antipsyc...
Policy Snapshot
June 17, 2022
Report From the AMA House of Delegates: AMA Supports Public Listing of Nursing Home Medical Directors
American Medical Association AMA House of Delegates Public Listing of Medical Directors health care transparency consumer access public listing of medical directors
Policy Snapshot
March 16, 2026
PALTmed Leads Coalition Effort to Overturn SNF Services Payment Reduction
PALTmed recently led a coalition of organizations in urging the Centers for Medicare & Medicaid Services (CMS) to reverse reductions to practice expense (PE) payments for services provided in skilled nursing facilities (SNFs). The cuts reduce payment for clinicians caring for patients in SNFs, despite ...
JAMDA
September 24, 2014
Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study
Behavioral and psychological symptoms of dementia (BPSD) are common reasons for use of antipsychotic drugs among older individuals with dementia. These drugs are not approved for such use and both the Food and Drug Administration and European Medicines Agency have issued warnings to limit such use.
JAMDA
August 9, 2018
Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia
Antipsychotic drugs are often used to treat behavioral and psychological symptoms (BPSD) in adults aged 65 years and older with dementia, although there is uncertainty about the effectiveness of long-term use for this indication and there are concerns that they may cause harm.
JAMDA
February 25, 2016
Reduction of Falls in Nursing Home by Improvement in Fall Assessment Accuracy and Early Nursing Interventions Leading to Improved Quality of Life and Substantial Cost Reduction and Improved Quality of Life
